Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 5Colonic Neoplasms 5Rectal Neoplasms 4Neoplasm Metastasis 4Neoplasms 3Carcinoma, Hepatocellular 2Bile Duct Neoplasms 2Vipoma 1Stomach Neoplasms 1Stage IV Fallopian Tube Cancer AJCC v6 and v7 1Somatostatinoma 1Pseudomyxoma Peritonei 1Pheochromocytoma 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms, Unknown Primary 1Liver Neoplasms 1Insulinoma 1Hyperthermia 1Glucagonoma 1Genetic Diseases, Inborn 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Gastrinoma 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Cirrhosis, Familial, with Pulmonary Hypertension 1Cholangiocarcinoma 1Carcinoma, Islet Cell 1Appendiceal Neoplasms 1

Interventions

Melphalan 3sargramostim 1romidepsin 1montanide ISA 51 1keyhole-limpet hemocyanin 1detox adjuvant 1Waiting Lists 1Thalidomide 1Radiosurgery 1Radiation 1Leucovorin 1Ketoconazole 1Interleukin-2 1Floxuridine 1FANG vaccine 1Docetaxel 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Genetic Diseases, Inborn × Floxuridine × Clear all
NCT00019760 2023-10-31

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡